Several studies on breast cancer have claimed that prediction models based on ML and utilizing various mpMRI features can predict the outcomes of neoadjuvant chemotherapy, the probability of recurrence or axillary lymph node metastasis, the level of Ki-67, and histological grade in luminal cancer [20,21,33,34]. The gene discussed is MKI67; the disease is breast cancer.